Pegloticase Intravenous and Pneumococcal 13-valent conjugate vaccine
Determining the interaction of Pegloticase Intravenous and Pneumococcal 13-valent conjugate vaccine and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: pegloticase
Brand name: Krystexxa
Synonyms: Pegloticase
Generic Name: pneumococcal 13-valent vaccine
Brand name: Prevnar 13
Synonyms: Pneumococcal Conjugate Vaccine (13-Valent)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Pegloticase Intravenous-Pneumococcal 13-valent vaccine, diphtheria conjugate Intramuscular
- Pegloticase Intravenous-Pneumococcal Conjugate Vaccine (13-Valent)
- Pegloticase Intravenous-Pneumococcal Conjugate Vaccine (7-Valent)
- Pegloticase Intravenous-Pneumococcal Polysaccharide Vaccine (23-Valent)
- Pegloticase Intravenous-Pneumococcal polysaccharides vaccine (PPSV), 23-valent
- Pegloticase Intravenous-Pneumovax 23
- Pneumococcal 13-valent conjugate vaccine-Pegvaliase
- Pneumococcal 13-valent conjugate vaccine-Pegvaliase-pqpz
- Pneumococcal 13-valent conjugate vaccine-Pegvaliase-pqpz Subcutaneous
- Pneumococcal 13-valent conjugate vaccine-Pegvisomant
- Pneumococcal 13-valent conjugate vaccine-Pegvisomant Subcutaneous
- Pneumococcal 13-valent conjugate vaccine-Pembrolizumab